AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Krish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCL
The HemOnc Pulse
BIS Antibodies in Oncology: Focus on CD3 and CD20 Targeting
This chapter delves into the efficacy and toxicity of CD3 and CD20 targeting antibodies in lymphoma treatments, with a spotlight on glutphimab in relapsed/refractory DLBCL. It also explores the concept of fixed duration therapy and compares glutphimab to other biospecific antibodies in large cell lymphoma.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode